D. Siegel

发表

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?

Sridevi Devaraj, S. Devaraj, I. Jialal, 2010, Current atherosclerosis reports.

Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay

S. Devaraj, I. Jialal, D. Siegel, 2017, Laboratory medicine.

Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.

A. Swislocki, D. Siegel, 2001, The American journal of managed care.

Prevalence and Treatment of Hypertension Complicated by Comorbid Conditions.

D. Siegel, J. Meier, Julio R Lopez, 1999, Journal of clinical hypertension.

The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin.

A. Swislocki, D. Siegel, J. Meier, 2010, Metabolic syndrome and related disorders.

Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

A. Swislocki, D. Siegel, 1999, JAMA.

Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.

V. Ernster, W. Hauck, D. Siegel, 1992, American journal of public health.

Smokeless tobacco use and health effects among baseball players.

B. Gerbert, N. Benowitz, V. Ernster, 1990, JAMA.

Adherence to and Persistence With Statin Therapy in a Veteran Population

A. Swislocki, D. Siegel, Julio R Lopez, 2018, The Annals of pharmacotherapy.

Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.

U. Singh, S. Devaraj, I. Jialal, 2008, The American journal of cardiology.

Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men.

B. Mackey, D. Kelley, Y. Adkins, 2012, Metabolic syndrome and related disorders.

Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines.

B. Adams-Huet, S. Devaraj, I. Jialal, 2014, Metabolic syndrome and related disorders.

Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.

B. Adams-Huet, I. Jialal, D. Siegel, 2017, Journal of diabetes and its complications.

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

S. Devaraj, I. Jialal, D. Siegel, 2007, The American journal of cardiology.

Simvastatin (40mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects with the Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2007 .

Exercise-induced hypertension: not quite ready for prime time.

D. Siegel, 2013, Metabolic syndrome and related disorders.

Resistant Hypertension and Undiagnosed Primary Hyperaldosteronism Detected by Use of a Computerized Database

A. Swislocki, D. Siegel, J. Meier, 2011, Journal of clinical hypertension.

Antibiotic Therapy for Premature Rupture of Membranes to Prevent Respiratory Distress Syndrome

D. Siegel, Julio R Lopez, Mph, 2022 .

Circadian variation in ventricular arrhythmias in hypertensive men.

D. Seeley, S. Hulley, D. Siegel, 1992, The American journal of cardiology.

Low vitamin D levels in Northern American adults with the metabolic syndrome.

S. Devaraj, I. Jialal, D. Siegel, 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Statin Intolerance in a Patient with Gilberts Syndrome and Hypercholesterolemia

I. Jialal, D. Siegel, MD I. Jialal, 2016, Experimental and Clinical Endocrinology & Diabetes Reports.

12 Managing Hypertension in Patients with Diabetes

A. Swislocki, D. Siegel, 2017 .

Managing Hypertension in Patients with Diabetes

A. Swislocki, D. Siegel, 2011 .

The ACCORD Study: the devil is in the details.

A. Swislocki, D. Siegel, 2011, Metabolic syndrome and related disorders.

Hypertensive treatment in patients with metabolic syndrome.

A. Swislocki, D. Siegel, 2010, Metabolic syndrome and related disorders.

The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients.

A. Swislocki, D. Siegel, J. Meier, 2008, American journal of hypertension.

Effects of antihypertensives on glucose metabolism.

A. Swislocki, D. Siegel, 2007, Metabolic syndrome and related disorders.

The influence of national guidelines on antihypertensive prescribing patterns

D. Siegel, 2000, Current hypertension reports.

Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996.

D. Siegel, D. Siegel, J. Meier, 1998, American journal of hypertension.

Trends in Antihypertensive Drug Use in the United States: Do the JNC V Recommendations Affect Prescribing?

David Siegel, Julio Lopez, D. Siegel, 1997 .

Glucose and insulin levels during diuretic therapy in hypertensive men.

S. Haffner, D. Siegel, P. Saliba, 1994, Hypertension.

Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw

L. Schwartz, S. Giri, D. Siegel, 1980, Inflammation.

Use of cholesterol-lowering medications in the United States from 1991 to 1997.

D. Siegel, J. Meier, Julio R Lopez, 2000, The American journal of medicine.

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2010, Current atherosclerosis reports.

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

B. Mackey, D. Kelley, D. Siegel, 2007, American Journal of Clinical Nutrition.

Concerns about the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 8 blood pressure panel member recommendations and their relevance to metabolic syndrome.

D. Siegel, 2014, Metabolic syndrome and related disorders.

Inflammation and Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2011 .

Antihypertensive medication adherence in the Department of Veterans Affairs.

Joy Meier, David Siegel, Julio Lopez, 2007, The American journal of medicine.

DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men.

B. Mackey, D. Kelley, Y. Adkins, 2009, The Journal of nutrition.

Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men.

B. Mackey, D. Kelley, D. Siegel, 2008, The Journal of nutrition.

Academic detailing to improve antihypertensive prescribing patterns.

M. Goldstein, D. Siegel, J. Meier, 2003, American journal of hypertension.

Inflammation, Atherosclerosis, and Psoriasis

S. Devaraj, I. Jialal, S. Raychaudhuri, 2013, Clinical Reviews in Allergy & Immunology.

Computer confirmation of improved blood pressure control in diabetic patients.

R. Noth, A. Swislocki, D. Siegel, 2009, Preventive cardiology.

Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.

F. Cunningham, D. Siegel, J. Meier, 2004, American journal of hypertension.

The gap between knowledge and practice in the treatment and prevention of cardiovascular disease.

D. Siegel, D. Siegel, 2000, Preventive cardiology.

Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy.

M. Cheitlin, D. Seeley, S. Hulley, 1990, The American journal of cardiology.

CRP induces hypertension in animal models: homo sapiens says NO

S. Devaraj, I. Jialal, D. Siegel, 2011, Hypertension Research.

Barriers to and Strategies for Effective Blood Pressure Control

D. Siegel, 2005, Vascular health and risk management.

Silent myocardial ischemia in men with systemic hypertension and without clinical evidence of coronary artery disease.

M. Cheitlin, D. Seeley, S. Hulley, 1992, The American journal of cardiology.

Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men.

S B Hulley, M. Cheitlin, D. Seeley, 1992, JAMA.

Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.

F. Cunningham, D. Siegel, J. Meier, 2001, American journal of hypertension.

The role of dyslipidemia in diabetic retinopathy: a brighter focus?

I. Jialal, D. Siegel, U. Rajamani, 2014, Journal of diabetes and its complications.

Posttraumatic stress disorder and metabolic syndrome: more questions than answers.

D. Schwenke, D. Siegel, 2013, Metabolic syndrome and related disorders.

Access to Mohs Surgery through the Choice program of the United States Department of Veterans Affairs.

R. Isseroff, D. Siegel, R. A. Cortez, 2020, Journal of the American Academy of Dermatology.

Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.

R. Noth, A. Swislocki, D. Siegel, 2002, The American journal of managed care.

Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.

D. Siegel, D Siegel, J Lopez, 1997, JAMA.

Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma.

A. Gelb, D. Sheppard, D. Siegel, 1985, The American review of respiratory disease.

Docosahexaenoic Acid Supplementation Decreases Remnant-Like Particle-Cholesterol and Increases the ( n-3 ) Index in Hypertriglyceridemic Men 1 – 3

B. Mackey, D. Kelley, D. Siegel, 2007 .

Pharmacotherapy for the metabolic syndrome.

I. Jialal, A. Swislocki, D. Siegel, 2012, Current vascular pharmacology.

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

B. Mackey, D. Kelley, D. Siegel, 2007, The American journal of clinical nutrition.

Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men.

B. Mackey, D. Kelley, Y. Adkins, 2012, Metabolic syndrome and related disorders.

Low Vitamin D Levels in Northern American Adults with the Metabolic Syndrome

S. Devaraj, I. Jialal, D. Siegel, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.

B. Adams-Huet, I. Jialal, D. Siegel, 2017, Journal of diabetes and its complications.